期刊文献+

2017美国成人高血压预防、检测、评估及管理指南介绍 被引量:4

下载PDF
导出
摘要 《2017美国成人高血压预防、检测、评估及管理指南》于2017年11月13日在美国心脏协会(American Heart Association,AHA)科学年会上正式发布(以下简称2017版指南)[1]。与上一版指南相比,2017版指南的变动较大。本文就该指南内容进行摘译。
作者 喜杨 孙宁玲
出处 《中国医学前沿杂志(电子版)》 2017年第11期14-28,共15页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
  • 相关文献

二级参考文献22

  • 1Kotwani P, Kwarisiima D, Clark TD, et al. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study[J]. BMC Public Health, 2013,13(1): 1151.
  • 2Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study[J]. Am J Med 1995, 98(5):476-484.
  • 3New approaches to antiarrhythmic therapy, part II: emer- ging therapeutic applications of the cell biology of cardiac arrhythmias[J]. Circulation, 2001,104(24):2990-2994.
  • 4Makkar KM, Sanoski CA, Spinier SA. Role of angioten- sin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias[J]. Pharmaco- therapy, 2009,29(1):31-48.
  • 5Jibrini MB, Molnar J, Arora RR. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis[J]. Am J Therb, 2008,15(1):36-43.
  • 6Anand K, Mooss AN, Hee TT, et al. Meta-analysis: inhi- bition of renin-angiotensin system prevents new-onset atrial fibrillation[J]. Am Heart J, 2006,152(2):217-222.
  • 7Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis[J]. J Am Coil Cardiol, 2005, 45(11):1832-1839.
  • 8Higgins JP, Thompson SG, Deeks JJ, et al. Measuring incon- sistency in meta-analyses[J]. BMJ, 2003,327(7414):557-560.
  • 9Armitage P, Berry G, Matthews JNS. Analysing Means and Proportions. Statistical Methods in Medical Research[J]. Blackwell Science Ltd 2008:83-146.
  • 10Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study[J]. J Am Coll Cardiol, 2005,45(5):712-719.

共引文献7

同被引文献27

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部